Skok, Kristijan
Stelzl, Evelyn
Trauner, Michael
Kessler, Harald H.
Lax, Sigurd F. http://orcid.org/0000-0002-3576-601X
Funding for this research was provided by:
Johannes Kepler University Linz
Article History
Received: 19 June 2020
Revised: 22 July 2020
Accepted: 6 August 2020
First Online: 20 August 2020
Compliance with ethical standards
:
: Dr. Lax reports personal fees from Roche, AstraZeneca, Novartis, and Biogena outside the submitted work. Dr. Trauner has received speaker fees from Bristol-Myers Squibb, Falk, Gilead, Intercept and Merck Sharp & Dohme (MSD); advisory board fees from Albireo, Boehringer Ingelheim, BiomX, Falk, Genfit, Gilead, Intercept, Jannsen, MSD, Novartis, Phenex, and Regulus; travel grants from AbbVie, Falk, Gilead, and Intercept; and research grants from Albireo, CymaBay, Falk, Gilead, Intercept, MSD, and Takeda. Authors not named here have disclosed no conflict of interest.